Identification of circulating murine CD34⁺OCN⁺ cells

Area of Science:

• Hematology
• Bone Biology
• Regenerative Medicine

Background:

• Previous studies identified circulating human osteoblastic cells expressing osteocalcin (OCN).
• A subpopulation of these cells expressed CD34, a hematopoietic and endothelial marker.
• This led to the hypothesis of circulating hematopoietic-derived CD34+OCN+ cells in mice, modulated by fracture.

Purpose of the Study:

• To identify and characterize circulating CD34+OCN+ cells in mice.
• To investigate the modulation of these cells following tibial fracture.
• To explore the potential role of CD34+OCN+ cells in fracture repair.

Main Methods:

• Flow cytometry was used to identify CD34+OCN+ cells in two mouse models.
• Non-stabilized tibial fractures were created and imaged using micro-computed tomography.
• Immunofluorescent staining and AMD3100 injection were employed to evaluate cell populations.

Main Results:

• Circulating CD34+OCN+ cells of hematopoietic origin (CD45+, Vav1+) were identified in mice.
• Both circulating and bone marrow CD34+OCN+ cells peaked three weeks post-fracture.
• AMD3100 treatment altered CD34+OCN+ cell levels in peripheral blood and bone marrow.

Conclusions:

• A murine CD34+OCN+ circulating population was demonstrated.
• These cells may be directly involved in fracture repair.
• Future studies will focus on molecular characterization and the correlation with fracture healing outcomes.